Invivyd (IVVD) EBIT (2021 - 2025)

Invivyd has reported EBIT for 5 years, with the latest figure at -$12.6 million in Q4 2025.

• For the quarter ending Q4 2025, EBIT rose 34.71% year-over-year to -$12.6 million; the trailing twelve-month figure through Dec 2025 stood at -$55.6 million (up 68.59% YoY), and the FY2025 full-year result was -$55.6 million, up 68.59% from the prior year.
• EBIT for Q4 2025 stood at -$12.6 million, down from -$11.0 million in the prior quarter.
• The five-year high for EBIT was -$11.0 million in Q3 2025, with the low at -$100.7 million in Q1 2022.
• Historically, EBIT has averaged -$46.0 million across 5 years, with a median of -$46.7 million in 2022.
• Annual changes were most pronounced in 2022 — EBIT plunged 160.25% — and 2025, when it soared 82.31%.
• Invivyd's EBIT stood at -$83.1 million in 2021, then soared by 41.98% to -$48.2 million in 2022, then tumbled by 59.2% to -$76.8 million in 2023, then soared by 74.95% to -$19.2 million in 2024, then soared by 34.71% to -$12.6 million in 2025.
• The last three EBIT figures came in at -$12.6 million (Q4 2025), -$11.0 million (Q3 2025), and -$15.1 million (Q2 2025), per Business Quant data.